Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...

Reports as of December 31, Corvus had cash, cash equivalents and marketable securities of $52.M as compared to $27.1M as of December 31, 2023.

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share. For the year, the company ...

BURLINGAME, Calif. (AP) — BURLINGAME, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. On a per-share basis, the Burlingame ...

The LUNA™ Reusable Slide is used for cell counting with the LUNA™ family of automated cell counters and CELENA™ S Digital Imaging System. The LUNA™ Reusable Slide may be used for both ...

There are, however, on this planet, phenomena that are hidden in plain sight. These are the phenomena that we study as complex systems: the convoluted exhibitions of the adaptive world — from cells to ...